C07D311/78

TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS AGAINST HIV/AIDS

Various embodiments relate to a compound of the formula (I) and (II), wherein X, X.sup.1, X.sup.2, X.sup.3, and R.sup.1-R.sup.4 am defined herein, as well as pharmaceutical compositions comprising compounds of the formula (I) and/or (II) and methods of treating an HIV infection comprising administering a therapeutically effective amount of one or more compounds of formula (I) and/or (II), or a pharmaceutical composition comprising compounds of the formula (I) and/or (II), to a patient in need thereof.

TRICYCLIC P2-LIGAND CONTAINING POTENT HIV-PROTEASE INHIBITORS AGAINST HIV/AIDS

Various embodiments relate to a compound of the formula (I) and (II), wherein X, X.sup.1, X.sup.2, X.sup.3, and R.sup.1-R.sup.4 am defined herein, as well as pharmaceutical compositions comprising compounds of the formula (I) and/or (II) and methods of treating an HIV infection comprising administering a therapeutically effective amount of one or more compounds of formula (I) and/or (II), or a pharmaceutical composition comprising compounds of the formula (I) and/or (II), to a patient in need thereof.

CANNABINOIDS AND USES THEREOF

The invention relates to cannabinoid compounds, pharmaceutical compositions including one or more cannabinoid compounds, and the use of pharmaceutical compositions including one or more cannabinoid compounds for the treatment of a disease or condition (e.g., a fibrotic disease or an inflammatory disease) in a subject in need thereof.

CANNABINOIDS AND USES THEREOF

The invention relates to cannabinoid compounds, pharmaceutical compositions including one or more cannabinoid compounds, and the use of pharmaceutical compositions including one or more cannabinoid compounds for the treatment of a disease or condition (e.g., a fibrotic disease or an inflammatory disease) in a subject in need thereof.

A SET OF MITOCHONDRIA-TARGETED COMPOUNDS

Here are described SkQ compounds containing cations of various types: alkyl(triphenyl)phosphonium cation, quaternary ammonium cations, including pH-dependent and permanent cations of rhodamines, berberine and palmatine alkaloids.

A SET OF MITOCHONDRIA-TARGETED COMPOUNDS

Here are described SkQ compounds containing cations of various types: alkyl(triphenyl)phosphonium cation, quaternary ammonium cations, including pH-dependent and permanent cations of rhodamines, berberine and palmatine alkaloids.

Urolithins-containing aqueous solution, dried solid composition thereof and production method therefor, and urolithins stabilizing method
11066381 · 2021-07-20 · ·

A urolithin-containing aqueous solution containing urolithin and collagen, a dried solid composition thereof, methods for producing these, and a stabilization method for urolithin.

Urolithins-containing aqueous solution, dried solid composition thereof and production method therefor, and urolithins stabilizing method
11066381 · 2021-07-20 · ·

A urolithin-containing aqueous solution containing urolithin and collagen, a dried solid composition thereof, methods for producing these, and a stabilization method for urolithin.

Cannabis extracts

A method is provided for removing THC from raw cannabis oil.

Cannabis extracts

A method is provided for removing THC from raw cannabis oil.